SBI Life Insurance Company Ltd (NSE: SBILIFE)
Investment Recommendation: BUY
Target Price: ₹2,000
Time Horizon: 12–18 months

---

Executive Summary

SBI Life Insurance Company Ltd, one of India’s top private life insurers, has shown solid growth fundamentals backed by rising profitability, robust margins, a healthy balance sheet, and increasing persistency ratios. The company is well-positioned to leverage the under-penetrated Indian insurance market through a balanced product portfolio and strategic partnerships. Despite a slight dip in premium income in Q4, SBI Life’s overall fiscal performance remains strong, justifying a BUY recommendation with a target of ₹2,000 in 12–18 months.

---

Company Overview

• Founded: March 2001
• Headquarters: Mumbai, Maharashtra
• CEO & MD: Amit Jhingran
• Promoters: State Bank of India and BNP Paribas Cardif
• Listed On: NSE & BSE (NIFTY 50 constituent)
• Core Business: Life insurance (individual and group policies, protection plans, annuities, and ULIPs)

---

Stock Snapshot (as of May 9, 2025)

• Current Market Price: ₹1,699.80
• 52-Week Range: ₹1,307.70 – ₹1,936.00
• Market Capitalization: ₹1.70 trillion
• Price-to-Earnings (TTM): 70.59
• Price-to-Book Ratio: 10.22
• Dividend Yield: 0.15%
• Beta: 0.80 (low volatility)
• Promoter Holding: 55.38%
• FII Holding: 21.88%
• DII Holding: 18.67%
• Dividend: ₹2.70 per share (declared February 2025)
• Next Earnings Release: July 29, 2025

---

Financial Performance

Q4 FY25 Highlights

• Net Profit: ₹813.5 crore (up slightly YoY)
• Total Premium Income: ₹23,861 crore, down 5.1% YoY
  • First-Year Premium: ₹4,859 crore (+7.3% YoY)
  • Renewal Premium: ₹14,680 crore (+12.9% YoY)
  • Single Premium: ₹4,463 crore (−42.1% YoY)
• Annualized Premium Equivalent (APE): ₹5,450 crore (+2% YoY)
• Value of New Business (VNB): ₹1,660 crore (+10% YoY)
• VNB Margin: 30.4% (vs 28.3% in Q4 FY24)
• Assets Under Management: ₹4.48 lakh crore (+15% YoY)
• 13-Month Persistency Ratio: 86.6% (up from 85.8%)
• Solvency Ratio: 1.96x (well above regulatory minimum of 1.50x)

FY25 Full-Year Highlights

• Net Profit: ₹2,413 crore (+27% YoY)
• Total Premium Income: ₹84,060 crore (+4.3% YoY)
• New Business Premium: ₹35,577 crore (down from ₹38,238 crore)
• Renewal Premium: ₹49,408 crore (+10.9% YoY)
• APE: ₹21,417 crore (+9% YoY)
• VNB: ₹5,954 crore (+7% YoY)
• VNB Margin: 27.8%
• Embedded Value (IEV): ₹70,250 crore (+21% YoY)
• Operating Return on Embedded Value: 20.2%
• Net Worth: ₹16,980 crore (+14% YoY)

---

Investment Rationale

Strong Profitability and Consistent Growth
SBI Life’s FY25 profit grew by 27% year-over-year, reflecting strong underlying business momentum. Continued growth in high-margin product segments and disciplined expense management contribute to long-term profitability.

Balanced Product Mix and Margin Expansion
The company has strategically shifted its focus toward non-participating and protection plans. In Q4 FY25, protection business rose by 22%, and non-par products grew by 51%. This change boosted VNB margins to 30.4%, enhancing future value generation.

Market Leadership with SBI Distribution Advantage
SBI Life leads the private sector in Individual Rated Premiums (₹19,350 crore in FY25), holding a 22.8% market share. It benefits from SBI’s extensive pan-India branch network and trusted brand, giving it a competitive distribution edge.

Robust Financial Stability
With a solvency ratio of 1.96x and 94% of its investment portfolio rated AAA or sovereign, SBI Life has a strong financial cushion and low-risk exposure, ensuring resilience across economic cycles.

Industry Tailwinds
India’s life insurance penetration remains below global averages. A rising middle class, tax incentives, and growing awareness about insurance create strong long-term tailwinds. SBI Life is well-poised to capture incremental demand as financial literacy spreads.

---

Risks and Concerns

• High Valuation: Current P/E of 70+ may indicate stretched valuation compared to peers. However, premium valuation is justified by superior earnings growth and margin profile.
• Product Mix Volatility: Continued growth in lower-margin ULIPs may dilute profitability if not offset by protection or annuity plans.
• Regulatory Risk: Changes in insurance laws or tax treatment (e.g., exemption removal) can impact product attractiveness.
• Market Volatility: ULIP returns are tied to market performance, which may affect consumer sentiment and growth.

---

Analyst Recommendations

• Motilal Oswal: BUY – Target ₹2,000
• Citi: BUY – Target ₹2,100
• Goldman Sachs: BUY – Target ₹1,800
• Jefferies: BUY – Target ₹1,770
• Nomura: BUY – Target ₹1,800
• Morgan Stanley: Overweight – Target ₹1,910
• HSBC: BUY – Target ₹1,800

The consensus across major brokerages remains bullish with a price target range of ₹1,770–₹2,100, supported by solid earnings and high VNB growth.

---

Conclusion

SBI Life’s consistent profitability, expanding VNB margins, and strong operating metrics make it a compelling long-term investment. Its competitive advantage through SBI’s network, focus on high-margin protection products, and strong embedded value growth underpin a positive outlook. Despite short-term premium volatility and valuation sensitivity, the stock offers an attractive opportunity for long-term investors seeking exposure to the structurally growing Indian life insurance market.

Recommendation: BUY
Target Price: ₹2,000
Time Horizon: 12–18 months